Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptides | 7 | 2026 | 372 | 2.310 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 12 | 2025 | 59 | 2.220 |
Why?
|
| Vimentin | 2 | 2025 | 44 | 1.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2025 | 57 | 1.030 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1723 | 0.970 |
Why?
|
| Exosomes | 6 | 2017 | 126 | 0.870 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 67 | 0.770 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 67 | 0.770 |
Why?
|
| MicroRNAs | 2 | 2026 | 518 | 0.700 |
Why?
|
| Inflammation | 1 | 2026 | 758 | 0.650 |
Why?
|
| Apoptosis | 7 | 2019 | 1568 | 0.520 |
Why?
|
| Clusterin | 1 | 2017 | 9 | 0.520 |
Why?
|
| Cell Line, Tumor | 5 | 2026 | 2676 | 0.490 |
Why?
|
| HIV-1 | 11 | 2016 | 755 | 0.440 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 226 | 0.410 |
Why?
|
| Gene Products, nef | 4 | 2005 | 19 | 0.340 |
Why?
|
| HIV Infections | 5 | 2016 | 2586 | 0.330 |
Why?
|
| Receptors, CXCR4 | 3 | 2008 | 74 | 0.330 |
Why?
|
| Cytokines | 3 | 2026 | 678 | 0.290 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1019 | 0.280 |
Why?
|
| Humans | 20 | 2026 | 43102 | 0.260 |
Why?
|
| Surface Plasmon Resonance | 1 | 2025 | 42 | 0.230 |
Why?
|
| Female | 6 | 2026 | 24698 | 0.230 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 386 | 0.220 |
Why?
|
| Binding Sites | 2 | 2025 | 671 | 0.220 |
Why?
|
| Protein Binding | 3 | 2025 | 1082 | 0.220 |
Why?
|
| Cell Proliferation | 3 | 2022 | 1455 | 0.210 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 70 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 245 | 0.190 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 94 | 0.190 |
Why?
|
| Peptide Fragments | 2 | 2015 | 307 | 0.190 |
Why?
|
| Biofilms | 1 | 2024 | 184 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2026 | 968 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 432 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2019 | 23 | 0.150 |
Why?
|
| Virion | 3 | 2016 | 75 | 0.150 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 34 | 0.150 |
Why?
|
| Cell Movement | 1 | 2022 | 655 | 0.140 |
Why?
|
| Cell Line | 6 | 2019 | 1410 | 0.120 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 108 | 0.120 |
Why?
|
| Transfection | 5 | 2013 | 532 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 434 | 0.120 |
Why?
|
| China | 1 | 2015 | 229 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 1180 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2017 | 883 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 1542 | 0.110 |
Why?
|
| AIDS Dementia Complex | 1 | 2015 | 116 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2015 | 321 | 0.100 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 97 | 0.100 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 52 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2011 | 36 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 529 | 0.090 |
Why?
|
| Jurkat Cells | 3 | 2008 | 87 | 0.080 |
Why?
|
| Prevalence | 1 | 2015 | 1612 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2019 | 2157 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.080 |
Why?
|
| Transport Vesicles | 1 | 2010 | 22 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2016 | 1621 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2853 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 876 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2008 | 126 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 138 | 0.070 |
Why?
|
| Neuroglia | 1 | 2008 | 133 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 201 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 76 | 0.070 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 144 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 263 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2008 | 411 | 0.060 |
Why?
|
| Aged | 2 | 2015 | 8214 | 0.060 |
Why?
|
| United States | 1 | 2015 | 5205 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 5080 | 0.050 |
Why?
|
| Male | 3 | 2015 | 23409 | 0.050 |
Why?
|
| Adolescent | 1 | 2015 | 6081 | 0.050 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2004 | 9 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2004 | 36 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2004 | 67 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 95 | 0.050 |
Why?
|
| Middle Aged | 2 | 2015 | 12222 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 247 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1869 | 0.050 |
Why?
|
| Adult | 2 | 2015 | 13872 | 0.050 |
Why?
|
| Mutant Proteins | 2 | 2012 | 51 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 458 | 0.040 |
Why?
|
| Animals | 4 | 2019 | 16992 | 0.040 |
Why?
|
| Brain | 1 | 2008 | 1472 | 0.040 |
Why?
|
| Protein Transport | 2 | 2011 | 296 | 0.040 |
Why?
|
| Mice | 2 | 2008 | 6644 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 512 | 0.040 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 14 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 127 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 310 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 348 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 536 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 189 | 0.020 |
Why?
|
| Static Electricity | 1 | 2012 | 86 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 182 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 272 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 506 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 148 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3735 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 229 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 423 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 486 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 188 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1070 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 25 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1759 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 209 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 296 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Neurons | 1 | 2015 | 1263 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 181 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 173 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 318 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 329 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 38 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 98 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 1177 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2005 | 158 | 0.010 |
Why?
|
| HIV-2 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Cyclophilin A | 1 | 2004 | 19 | 0.010 |
Why?
|
| Hela Cells | 1 | 2004 | 376 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 279 | 0.010 |
Why?
|